Biomarkers: a biomarker, or biological marker, generally refers to a measurable indicator of some biological state or condition. The term is also occasionally used to refer to a substance, the presence of which indicates the existence of a living organism. Further, life forms are known to shed unique chemicals, including DNA, into the environment as evidence of their presence in a particular location.
-
MAY 13, 2025 | 8:15 AM
C.E. CREDITS
Webinar 2 will focus on specimen types, specimen management, extraction, quantification, and various types of library preparation (amplicon vs. hybrid capture) for DNA. We will also include...
Finding the right predictive and prognostic biomarkers is essential for improving cancer treatment. In this 30 min webinar, we’ll explore how NGS proteomics, combined with genomics , p...
Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting the joints, entheses, and skin, while also increasing the risk of cardiovascular disease (CVD) and metabolic dysfunction...
Liquid biopsy, a noninvasive method used for analysis of circulating biomarkers like tumor cells, DNA, and exosomes from bodily fluids, shows promise in advancing cancer research for future...
MAR 07, 2025 | 1:00 PM
C.E. CREDITS
Ovarian cancer remains a significant challenge in women's health, with high mortality rates due to late-stage diagnosis. This webinar aims to provide healthcare professionals with an in-...
MAR 07, 2025 | 11:30 AM
C.E. CREDITS
El cáncer de ovario sigue siendo un desafío importante para la salud de las mujeres, con altas tasas de mortalidad debido al diagnóstico en etapa tardía. Este sem...
Antibody-drug conjugates (ADCs) are a novel class of cancer therapeutics comprised of a linker-payload conjugated to a selective monoclonal antibody targeting a tumor-associated antigen (TAA...
Dr. Fraser's research is focused on the discovery and validation of diagnostic and prognostic biomarkers for complex diseases, including renal dysfunction, long-COVID, and sepsis. By leverag...
Using next-generation proteomics technologies, organoid-based research models have the potential to revolutionize drug discovery and personalized medicine, improving our understanding of neu...
In this webinar, Dr. Clarissa Yates, CEO of Ketim Therapeutics, will share her exciting results from a proteomics pilot study exploring biomarkers associated with postpartum depression (PPD)...
Precision Diagnosis of Ovarian Cancer – Identification of Protein Biomarkers that Separate Benign from Malignant Tumors Ovarian cancer has the highest mortality among gynecological can...
Tuberculosis (TB) remains a disease of global significance, causing 1.3 million deaths and 10.6 million cases of active disease worldwide each year. The World Health Organization (WHO) has i...
Dengue is rapidly emerging as a major global health threat, exacerbated by climate change and unplanned urbanization. This webinar will explore the increasing burden of dengue as it spreads...
New tools for plasma proteomics workflows Amarjeet Flora, M.S. Recent technological advancements have revitalized interest in plasma proteomics, helping to bridge the gap between laboratory...
Breast cancer is a highly aggressive disease linked to poor clinical outcomes. Understanding the complex tumor microenvironment (TME) would help to identify novel therapeutic targets to impr...
NOV 14, 2024 | 12:00 PM
C.E. CREDITS
Single-cell sequencing (scSeq) is transforming disease research by revealing the intricate diversity across cell populations, uncovering crucial biomarkers and therapeutic targets often mask...
NOV 13, 2024 | 10:00 AM
C.E. CREDITS
In 2022, there were approximately 1.4 million new cases of prostate cancer reported globally and over 397,000 deaths reported globally. PSA testing can have significant value in detecting me...
While a decade ago the prognosis of lung cancer patients was very disappointing, nowadays a substantial evolution is driven by targeted treatments and immuno-oncology. With extended, scaled...
In part 2 of this webinar, Dr. Emily Hodges, assistant professor of biochemistry at Vanderbilt University, will reveal new data that illustrates how the Hodges Lab is utilizing the 6-base ge...
OCT 30, 2024 | 8:00 AM
C.E. CREDITS
Predicting patient outcomes in cancer treatment is key to creating personalized and effective therapeutic plans. Join Dr. Osman in this engaging webinar as she delves into the cutting-edge w...
OCT 17, 2024 | 8:15 AM
C.E. CREDITS
In this first webinar, we will cover various applications for NGS and different aspects of comprehensive genomic tests, including variants, C...
The path from research discovery to effective immune cell therapies requires innovative approaches to match the challenges we face. Examining the full richness of biological complexity&mdash...